FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LIRAMETOSTAT
异名/同义词(R)-N-((4-METHOXY-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-2-METHYL-1-(1-(1-(2,2,2-TRIFLUOROETHYL)PIPERIDIN-4-YL)ETHYL)-1H-INDOLE-3-CARBOXAMIDE
1H-INDOLE-3-CARBOXAMIDE, N-((1,2-DIHYDRO-4-METHOXY-6-METHYL-2-OXO-3-PYRIDINYL)METHYL)-2-METHYL-1-((1R)-1-(1-(2,2,2-TRIFLUOROETHYL)-4-PIPERIDINYL)ETHYL)-
CPI-1205
EZH2 INHIBITOR CPI-1205
LIRAMETOSTAT
LIRAMETOSTAT [INN]
LIRAMETOSTAT [WHO-DD]
CAS登记号1621862-70-1
物质唯一标识(Unique Ingredient Identifier)455J2479FY
分子式C27H33F3N4O3
国际化合物标识(International Chemical Identifier,InChI)HPODOLXTMDHLLC-QGZVFWFLSA-N
SMILES[C@@H](C1CCN(CC(F)(F)F)CC1)(n2c(C)c(C(=O)NCc3c(=O)[nH]c(C)cc3OC)c4ccccc42)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System